Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Mitochondria-Targeted Iridium(III) Complexes Entrapped in Liposomes Induce Cell Death through Ferroptosis.

Created on 12 Nov 2026

Authors

Wenrun Zhu, Yajie Niu, Guirong Liu, Xiang Yu, Hui Yin, Shuanghui Tang, Yunjun Liu, Jiu Wang

Published in

Journal of medicinal chemistry. Volume 69. Issue 21. Pages 25807-25821. Nov 12, 2026.

Abstract

The anticancer efficacy of iridium(III) complexes has been extensively studied. A new ligand TFMPIP (2-(4-(trifluoromethoxy)phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline) and its four iridium(III) complexes [Ir(C-N)2(TFMPIP)]PF6 (C-N = ppy: 13a, bzq: 13b, piq: 13c, and dfppy: 13d) were synthesized and characterized. The complexes show moderate or low cytotoxicity against LA795, HCT116, and Huh7 cells, while their liposome formulations 13a@lipo, 13b@lipo, 13c@lipo, and 13d@lipo significantly enhanced the antiproliferative activity against LA795 cells. Mechanistic investigations revealed that 13a@lipo, 13b@lipo, 13c@lipo, and 13d@lipo accumulated in mitochondria and induced pronounced mitochondrial dysfunction. Subsequent experiments confirmed that 13a@lipo, 13b@lipo, 13c@lipo, and 13d@lipo triggered apoptosis, suppressed the PI3K/AKT/mTOR signaling pathway, and induced ferroptosis. In vivo antitumor activity showed that 13c@lipo significantly inhibited tumor growth in the LA795 tumor-bearing model with a high inhibitory rate of 82.72%. Collectively, these findings identify 13c@lipo as a promising liposomal Ir(III)-based candidate for lung adenocarcinoma therapy.

PMID:
43018620
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement